Navigation Links
ChromaDex, Inc. Announces Completion of Reverse Merger With Cody Resources, Inc.
Date:7/1/2008

IRVINE, Calif., July 1 /PRNewswire/ -- ChromaDex, Inc. ("ChromaDex"), today announced that effective June 20, 2008, it completed its merger with CDI Acquisition, Inc. ("CDI"), the wholly-owned subsidiary of Cody Resources, Inc. ("Cody") (OTC Bulletin Board: CDYE). The transaction enables ChromaDex to be wholly owned by a company whose shares are publicly traded, which will help it be better positioned to meet the ongoing needs of a rapidly growing marketplace. The business and operations of ChromaDex prior to the merger continue unchanged after the merger, and ChromaDex should continue to meet demand for analytical tools, products, and services that help customers comply with regulatory, quality, efficacy and safety standards for their products.

The merger was completed pursuant to an Agreement and Plan of Merger dated May 21, 2008, by and among ChromaDex, Cody and CDI. As a result of the merger, ChromaDex became a wholly owned subsidiary of Cody, each outstanding share of ChromaDex common stock automatically converted into the right to receive one share of common stock of Cody and ChromaDex shareholders own or have the right to own, in the aggregate, approximately 23,522,122 shares, or 84% of the outstanding common stock of Cody. Also in connection with the Merger, Cody changed its state of incorporation from Nevada to Delaware and changed its name to ChromaDex Corporation.

"We are pleased to have completed this reverse merger as a means of achieving public ownership for ChromaDex," said Frank Jaksch, CEO and co-founder of ChromaDex. "This merger into the public arena affords ChromaDex benefits of public ownership, including the ability to enhance our visibility with customers and prospective customers, additional liquidity for existing and future equity investors, and access to potential additional avenues for capital formation to help us grow and expand to meet the needs of the sizable natural product chemistry, dietary supplement, functional
'/>"/>

SOURCE ChromaDex
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2009)...nd explosive materials and persons who have been i...ional Institute of Standards and Technology (NIST)...urity, has developed a new certified reference mat...ce Particulate Explosives. Compatible with field a...ul in calibrating, testing and developing standard...
(Date:11/18/2009)...ire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasda...ersity of Pennsylvania investigator sponsored Phas... (ZFN) based product, SB-728-T, for HIV/AIDS were ...ernet. ,, Data were presented in a student cour...icine from a single subject treated with SB-728-T ...
(Date:11/18/2009)...nd CLEVELAND, Nov. 18 TREK Diagnos...remier provider of diagnostic systems and suscepti...d its East Grinstead, U.K., manufacturing and rese...lobal demand for its Sensititre® product line...e expanded facility has been fully validated, and ...
(Date:11/18/2009)...and SwitchGear Genomics announce a novel method fo... Madison, WI, USA (PRWEB) Novem... Genomics announce a novel method for characterizi...ing the HaloCHIP™ System and high-throughput...ate DNA binding events to transcriptional activati...
Breaking Biology Technology:New NIST trace explosives standard slated for homeland security duty 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 3TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 4Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity 2
...tralia, March 27 /Xinhua-PRNewswire-FirstCall/ -- ... that Australian-made Aridol,(mannitol) has been i...lympic Committee,s independent Medical Commission....ed IOC Consensus,Statement on Asthma in Elite Athl...cs. The prevalence of asthma in elite athletes has...
...rch 27 /PRNewswire/ - IntelliPharmaCeutics Ltd. (D...s from a recently completed pilot,clinical trial f...-a-day,oral oxycodone formulation by its operating...ntelliPharmaCeutics" or the "Company"). The produc...s novel ReXista(TM) abuse and,alcohol resistant dr...
...onn., March 27 Core Informatics announces,that it...r web-based,Laboratory Information Management Syst...harmaceuticals Inc. (Nasdaq: PGNX ), a biopharmac...of the project, Progenics,required legacy data mig...he newly implemented system manages pre-clinical d...
Other Biology Technology:Aridol(TM) Endorsed by International Olympic Committee 2Aridol(TM) Endorsed by International Olympic Committee 3Aridol(TM) Endorsed by International Olympic Committee 4IntelliPharmaCeutics Announces Successful Completion of a Pilot Clinical Trial for its Abuse and Alcohol Resistant Sustained Release Oxycodone 2IntelliPharmaCeutics Announces Successful Completion of a Pilot Clinical Trial for its Abuse and Alcohol Resistant Sustained Release Oxycodone 3
(Date:11/19/2009)...e fungus for food, have many remarkable qualities.... farmers, like their human counterparts, depend on...ow. The finding, reported this week (Nov. 20) in t...wn symbiosis between ants and bacteria and provide...ominate the American tropics and subtropics. , W...
(Date:11/19/2009)...in maize, also known as corn, researchers across t...hould pave the way to significant improvements in ...al feed and fiber around the world. , The new ma... map, charts genetic diversity and recombination a...research team, led by U.S. Department of Agricultu...
(Date:11/19/2009)...scientists have helped identify and group the gene...ent in maize, an effort that expands their ability...ed for biofuels production. , The Purdue scienti... cell biology, published their findings on the 750... on Thursday (Nov. 19). They also were co-authors ...
Breaking Biology News(10 mins):Like humans, ants use bacteria to make their gardens grow 2Maize cell wall genes identified, giving boost to biofuel research 2New Data Support Use of Simple Test to Predict Endometrial Cancer Response to Chemotherapy 47457 1New Data Support Use of Simple Test to Predict Endometrial Cancer Response to Chemotherapy 47457 2New Data Support Use of Simple Test to Predict Endometrial Cancer Response to Chemotherapy 47457 3BD Biosciences Launches New Cell Analyzer for Complex Multicolor Experiments in Disease and Drug Development Research 47453 1BD Biosciences Launches New Cell Analyzer for Complex Multicolor Experiments in Disease and Drug Development Research 47453 2AGA Institute and Horizon Therapeutics Launch Connect to Protect Program to Educate Physicians and Consumers on Risks Associated With NSAID Use 12385 1AGA Institute and Horizon Therapeutics Launch Connect to Protect Program to Educate Physicians and Consumers on Risks Associated With NSAID Use 12385 2AGA Institute and Horizon Therapeutics Launch Connect to Protect Program to Educate Physicians and Consumers on Risks Associated With NSAID Use 12385 3
...nal Institute of Standards and Technology (NIST), ...y Detection Research Network (EDRN), has validated...se mitochondrial DNA as an early indicator for cer...hat a relatively simple diagnostic test using a DN...f some solid tumors, including lung cancer. , Mito...
... polarity in the developing mammalian embryo is on...biology today. Drs. Davor Solter and Takashi Hiira...sing various techniques, including comprehensive t...lling evidence for the absence of predetermined po...ontrast to those who feel that the site of sperm e...
...re tomorrow (21 July) will outline for the first t...eck and shoulders in vertebrates. The scientists b...ng the skeletal and muscle structure separately th... of ,composite,. This could have significant impli...g of vertebrate evolution. , Scientists at the Wol...
Other Biology News:Scientists discover stem cell origin of neck and shoulders 2
Mouse Anti-Kusabira Orange Monoclonal Antibody, Unconjugated, Clone 2G9 from MBL International
Anti-CD69 / CD3 Monoclonal Antibody, PE, PerCP Conjugated from BD Biosciences - Immunocytometry Systems
Rat Anti-Vitamin B3 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-CD18, phospho (Ser756 / Thr758 / Thr759) Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Biology Products: